Rafarma Pharmaceuticals, Inc. (RAFA)

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceutical	10.14M
Pharmaceutical Growth	-84.24%

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	10.14M
United States Growth	-84.24%